From: Application of exosomes in the diagnosis and treatment of pancreatic diseases
Diseases | Source | Molecules | Mechanism | Years | Ref |
---|---|---|---|---|---|
AP | Plasma | S100A8 S100A9 | Triggered NFκB activation, TNFα | 2022 | [33] |
 | PAAF Plasma | miR | High pro-inflammatory activity on macrophages | 2019 | [34] |
CP | Plasma | miR | High exosomal levels of miRNA-10b, miR-21, miR-30c, and miR-181a, and low levels of miR-let7a | 2017 | [22] |
PaCa | Serum | Protein miR | Excellent sensitivity for PaCa versus CP | 2015 | [39] |
 | PSC | miR | Stimulated the proliferation, migration, and expression of miRNAs for chemokine ligands | 2017 | [41] |
Diabetes | Urine | Protein | AQP5 and AQP2 were used to classify the clinical stages of diabetic nephropathy | 2017 | [51] |
 | Urine | miR | miR-145 may represent a novel biomarker for diabetic complications | 2013 | [52] |